PSEN2 and ovarian cancer: Supporting these findings, Steg and colleagues have reported increased transcript levels of stem cell pathway genes, including the Notch pathway member presenilin 2 (PSEN2), in recurrent ovarian cancer samples compared with matched primary tumors [96].